These findings suggest that one of the potential mechanisms in cancer recurrence could be the secretion of HMGB1 and the release of inhibitory cytokines by immune cells, which, in turn, adjust the tumor immune microenvironment [46]. This evidence concerns the gene HMGB1 and cancer.